SCHEMBL28364487

SCHEMBL28364487

[N-]=[N+]=NCCCCCCCC(=O)N1CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 6/20 0.43
▸ GNAI1 P63096 6/20 0.43
▸ GNAO1 P09471 5/20 0.43
▸ ITGB3 P05106 2/20 0.40
▸ ITGA2B P08514 2/20 0.40
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TPSAB1 Q15661 3/20 0.37
▸ TPSD1 Q9BZJ3 3/20 0.37
▸ TPSG1 Q9NRR2 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ EPHX2 P34913 1/20 0.35
▸ DDB1 Q16531 1/20 0.35
▸ CRBN Q96SW2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28364611 1.00 GNAI3 (0.43) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL28360951 1.00 GNAI3 (0.43) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL28361039 0.98 GNAI3 (0.41) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL28360975 0.94 ATM (0.41) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL28360880 0.87 CA2 (0.38) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL16756662 0.83 GNAI3 (0.56) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL10337915 0.83 GNAI3 (0.56) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL9415769 0.83 GNAI3 (0.56) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL9415827 0.83 GNAI3 (0.56) GNAI3GNAI1GNAO1ITGB3ITGA2B
SCHEMBL29969222 0.78 CA2 (0.39) TPSAB1TPSD1TPSG1KMT2ADDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845445-A Connecting body, preparation method and application thereof, and thalidomide-based PROTACs intermediate and application thereof 苏州爱玛特生物科技有限公司 2020-02-28 — — CN disclosed
Send feedback